Related Experiment Videos
Genotypic association between dopamine transporter gene polymorphisms and schizophrenia
1Department of Neuropsychiatric Sciences, S. Raffaele Hospital, Milan, Italy.
American Journal of Medical Genetics
|February 21, 1997
Summary
Dopamine transporter (DAT) gene variants are not a primary cause of schizophrenia. However, specific DAT genotypes may modify schizophrenia development, particularly in certain patient groups.
Area of Science:
- Neurogenetics
- Psychiatric Genetics
Background:
- Dopamine transporter (DAT) gene variants' role in schizophrenia etiology is debated.
- Previous linkage studies suggest limited widespread contribution to schizophrenia.
Purpose of the Study:
- To investigate the association between DAT gene polymorphisms and schizophrenia spectrum disorders.
- To explore potential modifying effects of DAT genotypes in specific schizophrenic subpopulations.
Main Methods:
- Compared polymorphic DAT gene variable number tandem repeat (VNTR) distributions.
- Analyzed 84 controls and 147 patients diagnosed with schizophrenia using DSM-IIIR criteria.
Main Results:
- No significant allelic association was found between DAT alleles and schizophrenia or its subtypes.
- A statistically significant departure in DAT genotype distribution was observed in schizophrenic patients compared to controls.
Conclusions:
- DAT gene variants do not appear to be a primary etiological factor in schizophrenia.
- Observed genotype distribution discrepancies may indicate assortative mating or a modifying role for DAT homozygote genotypes in schizophrenia pathogenesis.